Comparative study of single-nucleotide polymorphism array and next generation sequencing based strategies on triploid identification in preimplantation genetic diagnosis and screen
Triploidy occurred about 2-3% in human pregnancies and contributed to approximately 15% of chromosomally caused human early miscarriage. It is essential for preimplantation genetic diagnosis and screen to distinct triploidy sensitively. Here, we performed comparative investigations between MALBAC-NGS and MDA-SNP array sensitivity on triploidy detection. Self-correction and reference-correction algorism were used to analyze the NGS data. We identified 5 triploid embryos in 1198 embryos of 218 PGD and PGS cycles using MDA-SNP array, the rate of tripoidy was 4.17‰ in PGS and PGD patients. Our results indicated that the MDA-SNP array was sensitive to digyny and diandry triploidy, MALBAC-NGS combined with self and reference genome correction strategies analyze were not sensitive to detect triploidy. Our study demonstrated that triploidy occurred at 4.17‰ in PGD and PGS, MDA-SNP array could successfully identify triploidy in PGD and PGS and genomic DNA. MALBAC-NGS combined with self and reference genome correction strategies were not sensitive to triploidy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Oncotarget - 7(2016), 49 vom: 06. Dez., Seite 81839-81848 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xu, Jiawei [VerfasserIn] |
---|
Links: |
---|
Themen: |
Comparative Study |
---|
Anmerkungen: |
Date Completed 12.02.2018 Date Revised 13.11.2018 published: Print Citation Status MEDLINE |
---|
doi: |
10.18632/oncotarget.13247 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM266095836 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM266095836 | ||
003 | DE-627 | ||
005 | 20231224213733.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.18632/oncotarget.13247 |2 doi | |
028 | 5 | 2 | |a pubmed24n0887.xml |
035 | |a (DE-627)NLM266095836 | ||
035 | |a (NLM)27833086 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xu, Jiawei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparative study of single-nucleotide polymorphism array and next generation sequencing based strategies on triploid identification in preimplantation genetic diagnosis and screen |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.02.2018 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Triploidy occurred about 2-3% in human pregnancies and contributed to approximately 15% of chromosomally caused human early miscarriage. It is essential for preimplantation genetic diagnosis and screen to distinct triploidy sensitively. Here, we performed comparative investigations between MALBAC-NGS and MDA-SNP array sensitivity on triploidy detection. Self-correction and reference-correction algorism were used to analyze the NGS data. We identified 5 triploid embryos in 1198 embryos of 218 PGD and PGS cycles using MDA-SNP array, the rate of tripoidy was 4.17‰ in PGS and PGD patients. Our results indicated that the MDA-SNP array was sensitive to digyny and diandry triploidy, MALBAC-NGS combined with self and reference genome correction strategies analyze were not sensitive to detect triploidy. Our study demonstrated that triploidy occurred at 4.17‰ in PGD and PGS, MDA-SNP array could successfully identify triploidy in PGD and PGS and genomic DNA. MALBAC-NGS combined with self and reference genome correction strategies were not sensitive to triploidy | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a MALBAC | |
650 | 4 | |a SNP array | |
650 | 4 | |a next generation sequencing | |
650 | 4 | |a preimplantation genetic diagnosis and screen | |
650 | 4 | |a triploidy | |
700 | 1 | |a Niu, Wenbin |e verfasserin |4 aut | |
700 | 1 | |a Peng, Zhaofeng |e verfasserin |4 aut | |
700 | 1 | |a Bao, Xiao |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Meixiang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Linlin |e verfasserin |4 aut | |
700 | 1 | |a Du, Linqing |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Nan |e verfasserin |4 aut | |
700 | 1 | |a Sun, Yingpu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 7(2016), 49 vom: 06. Dez., Seite 81839-81848 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2016 |g number:49 |g day:06 |g month:12 |g pages:81839-81848 |
856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.13247 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2016 |e 49 |b 06 |c 12 |h 81839-81848 |